RACELLET 3 PELLETS
Natural health product licensed in Canada
- Licence holder
- Pascal International Corporation
- NPN or DIN-HM
- 00407674
- Status
- Active licence
- Licence date
- 5 December 2007
- Revision date
- Not provided
- Form
- Perles
- Route of administration
- Dentaire
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Chlorure de sodium, FD & C Yellow No. 10 Aluminum Lake, Benzoate de sodium, Phosphate de sodium, monobasique, FD & C bleu #1, Acide citrique, Cotton pellet
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | minimum: 1 pellet ; maximum: 4 pellet | Not specified |
| Adultes | Not specified | minimum: 1 pellet ; maximum: 4 pellet | Not specified |
Uses authorised in Canada
Use in professional dental practice for local dental hemostasis and local tissue retraction. Racellet 3 pellets will control capillary oozing and tissue engorgement through temporary vasoconstriction.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
RACELLETS pellets should be used with caution on patients suffering from diabetes, cardiovascular disease, hypertension, or hyperthyroidism.
Source
Official Health Canada record, licence 00407674
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.